| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.079 | 0.7 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |